Table 2 Clinical characteristic of DVT in 91 subjects
Characteristics of DVT | n (%) |
|---|---|
Extremity affected by DVT | |
Unilateral | 72 (79.1) |
Bilateral | 19 (20.9) |
Number of veins affected by DVT | |
Single | 45 (49.5) |
Multiple | 46 (50.5) |
Thrombus location | |
Proximal only | 80 (87.9) |
Distal only | 1 (1.1) |
Proximal-distal | 10 (11) |
Risk factor of DVT | |
Unprovoked DVT (idiopathic)* | 43 (47.3) |
Immobilization | 17 (18.7) |
Malignancy | 16 (17.6) |
Central vein catheterization in femoral vein | 7 (7.7) |
Surgery | 4 (4.4) |
Trauma | 4 (4.4) |
Number of DVT risk factor | |
One risk factor | 81 (89) |
More than one risk factor | 10 (11) |
Anticoagulant Therapy | |
Unfractionated heparin/warfarin | 43 (47.3) |
Low molecular weight heparin/warfarin | 5 (5.5) |
Fondaparinux/warfarin | 6 (6.6) |
Warfarin only | 23 (25.3) |
Rivaroxaban | 8 (8.8) |
Others (acetylsalicylate, herbal medicine) | 2 (2.2) |
No therapy | 4 (4.4) |
Anticoagulant Duration | |
< 3 months | 31 (36.5) |
3–6 months | 20 (23.5) |
> 6 months | 35 (40) |